Novel findings on GRB2 and SOS1 could pave the way for cancer treatments

Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.

CDER tweaks Ozempic’s post-marketing label to include risk for GI disorder

CDER has added two post-marketing caveats to the label of Novo Nordisk’s blockbuster diabetes drug Ozempic, including a warning for a condition related to a

September 29, 2023

Q&A: How this federal court ruling helps nursing home residents with disabilities

Over the last 30 years, one of the biggest shifts in health policy for Americans with disabilities has been an emphasis on helping people live

January 14, 2025

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients on GLP-1 medications for weight management. The study highlights

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.